Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03123549 · ClinicalTrials.gov registry record · NA
Investigation of the Two Level Simplify® Cervical Artificial Disc
A NA study, sponsored by NuVasive.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
NCT03123549 is a NA study that has completed, run by NuVasive. The registered enrollment target is 182 participants.
The verdict
NCT03123549, a NA study, has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
Study Summary
This study is intended to demonstrate that the Simplify® Cervical Artificial Disc (Simplify® Disc) is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) when used to treat two contiguous discs from C3 to C7 following discectomy at two contiguous levels for intractable radiculopathy (arm pain and/or a neurological deficit) with neck pain or myelopathy due to abnormalities localized to the levels of the two contiguous disc spaces in subjects who are unresponsive to conservative management.
Interventions
- DEVICE Simplify Disc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2022-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03123549
The ClinicalTrials.gov registry entry for NCT03123549 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Simplify Disc is the first listed.
NCT03123549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03123549 about?
NCT03123549 is a clinical study titled "Investigation of the Two Level Simplify® Cervical Artificial Disc". This study is intended to demonstrate that the Simplify® Cervical Artificial Disc (Simplify® Disc) is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) when used to treat two contiguous discs from C3 to C7 following discectomy at two contiguous levels for ...
What is the current status of trial NCT03123549?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2017-04-01. Estimated completion is 2022-03-24.
What interventions are being tested in trial NCT03123549?
The interventions under investigation include: Simplify Disc (DEVICE).
Who is sponsoring clinical trial NCT03123549?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.